Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
MD

NASDAQ · MDAI

Spectral AI, Inc.

Healthcare · Medical - Devices

$1.53

Up+$0.03 (+2.00%)

Updated Nov 5, 2026, 3:43 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
52.94M
P/E ratio
-3.06
Dividend yield
0.00%
52-week range
$1.18 – $2.97
Volume
103.33K
Avg. volume
592.78K

Price performance · MDAI

MDAI price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

MDAI closed at $1.53 after 21 trading sessions, down 6.71% for the selected period.

Last close
$1.53
Period change
-6.71%
Period low
$1.44
Period high
$1.65
Daily close
View OHLC price history
MDAI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$1.51$1.58$1.51$1.53103.33K
Nov 3, 2026$1.52$1.55$1.49$1.50167.25K
Nov 2, 2026$1.53$1.55$1.48$1.52131.79K
Oct 30, 2026$1.55$1.56$1.49$1.53120.79K
Oct 29, 2026$1.58$1.58$1.535$1.5767.9K
Oct 28, 2026$1.54$1.625$1.52$1.56286.03K
Oct 27, 2026$1.49$1.54$1.48$1.5355.52K
Oct 26, 2026$1.44$1.50$1.44$1.5038.18K
Oct 23, 2026$1.50$1.50$1.43$1.44131.63K
Oct 22, 2026$1.5008$1.52$1.49$1.5061.23K
Oct 21, 2026$1.51$1.52$1.49$1.5151.56K
Oct 20, 2026$1.525$1.54$1.48$1.5161.77K
Oct 19, 2026$1.50$1.53$1.50$1.5253K
Oct 16, 2026$1.53$1.55$1.485$1.5199.67K
Oct 15, 2026$1.52$1.56$1.49$1.54177.43K
Oct 14, 2026$1.54$1.5789$1.50$1.53228.91K
Oct 13, 2026$1.61$1.62$1.54$1.56178.23K
Oct 12, 2026$1.65$1.65$1.60$1.6075.17K
Oct 9, 2026$1.64$1.68$1.64$1.65154.07K
Oct 8, 2026$1.63$1.678$1.62$1.6498.19K
Oct 7, 2026$1.65$1.68$1.61$1.6493K

Latest MDAI news

The latest Smart Investors Daily articles mentioning MDAI.

Stock researchCompany · Overview

MDAI research

Overview

Company profile and research snapshot.

Company profile

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.50
Implied upside
—
Analysts
—
MDAI recent ratings
DateFirmRatingTarget
May 27, 2026BTIGBuy—
May 26, 2026BTIGBuy—
Mar 25, 2026BTIGBuy—
Feb 10, 2026BTIGBuy—
Nov 12, 2025BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 28, 2026

Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call

DALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2026 on Tuesday, November 10, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on

Yahoo · Oct 13, 2026

Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly

DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today highlighted its participation at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly, held October 5-8 in Chicago, IL. The Company showcased its FDA-cleared DeepView™ System for Burn Indication at this year’s Assembly. Widely

Yahoo · Oct 6, 2026

Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System

DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the submission of a New Technology Add-On Payment (NTAP) application to the Centers for Medicare & Medicaid Services (CMS) for its DeepView™ System utilizing the alternative pathway. The NTAP program is designed to provide an additional hos

Yahoo · Oct 1, 2026

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit (“SIV”) associated with the commencement of a clinical study designed to support a label expansion of the Company’s FDA-cleared DeepView System™ for Burn Indication to include burns involvin

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By